Assignee
ANGIOGENE PHARM LTD
GB·10 granted patents·4 pending applications·77 citations·filing 1998–2013
Top patents by PatentIndex Score
14 records- 0183US7875727B2Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2006·Granted Jan 25, 2011·4 cites·31 claims
- 0277US6645950B1Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2000·Granted Nov 11, 2003·8 cites·6 claims
- 0376US7087627B1Combinations for the treatment of diseases involving angiogenesisANGIOGENE PHARM LTD·Filed 2000·Granted Aug 8, 2006·7 cites·19 claims
- 0473US6720323B2Colchinol derivatives as angiogenesis inhibitorsANGIOGENE PHARM LTD·Filed 2001·Granted Apr 13, 2004·5 cites·16 claims
- 0571US7105501B2Compositions with vascular damaging activityANGIOGENE PHARM LTD·Filed 2003·Granted Sep 12, 2006·6 cites·14 claims
- 0669US7265136B1Substituted stilbene compounds with vascular damaging activityANGIOGENE PHARM LTD·Filed 2000·Granted Sep 4, 2007·4 cites·17 claims
- 0768US6423753B1Use of colchinol derivatives as vascular damaging agentsANGIOGENE PHARM LTD·Filed 1998·Granted Jul 23, 2002·37 cites·16 claims
- 0864US7081469B2Benzimidazole vascular damaging agentsANGIOGENE PHARM LTD·Filed 2003·Granted Jul 25, 2006·1 cites·14 claims
- 0963US6846925B2Colchinol derivatives as angiogenesis inhibitorsANGIOGENE PHARM LTD·Filed 2003·Granted Jan 25, 2005·1 cites·13 claims
- 1052US2006198846A1Combinations for the treatment of diseases involving angiogenesisANGIOGENE PHARM LTD·Filed 2006·Application pending·0 cites
- 1151US2006128633A1Colchinol derivatives as vascular damaging agentsANGIOGENE PHARM LTD·Filed 2005·Application pending·0 cites
- 1243US2015141349A1Method and Composition for Alleviating Tumor SymptomsANGIOGENE PHARM LTD·Filed 2013·Application pending·0 cites
- 1342US7135502B1Colchinol derivatives as vascular damaging agentsANGIOGENE PHARM LTD·Filed 1999·Granted Nov 14, 2006·4 cites·13 claims
- 1437US2008145372A1Bioreductively-Activated ProdrugsANGIOGENE PHARM LTD·Filed 2005·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →